To rule out a role for MYCN in regulating MYO1B in MNA+ NB, we performed shRNA or siRNA KD of MYCN, neither of which decreased MYO1B protein expression in the MNA+ NB cell lines NGP, Kelly, and BE2C (fig. The gene discussed is MYCN; the disease is neuroblastoma.